Special Report

Special Report Andrew Joseph

To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA

Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup

Facebook is receiving sensitive medical information from hospital websites

Special Report Angus Chen

‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a waitlist

Special Report Jonathan Moens

Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up

Special Report Tara Bannow

Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines

Special Report Lev Facher

NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads

Special Report Rachel Cohrs

Why formally ending the pandemic is going to be a huge headache for the entire health care system

Special Report Usha Lee McFarling

The nation hasn’t made much progress on health equity. These leaders forged ahead anyway

Special Report Casey Ross

How a decades-old database became a hugely profitable dossier on the health of 270 million Americans

Special Report Isabella Cueto

Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain

Special Report Damian Garde

It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall

Special Report Olivia Goldhill — STAT and Rosa Furneaux and Madlen Davies — TBIJ

‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world

Special Report Bethany Mollenkof

A hospital, and a family, lost during the pandemic

Special Report Bethany Mollenkof

A community pioneer lost, and remembered

Special Report Bethany Mollenkof

The land as medicine

Special Report Bethany Mollenkof

The Guardian of the Glades

Special Report Bethany Mollenkof

DISTANCED: Pandemic stories of Black life in the rural South

Exclusive Nicholas Florko

‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby

Special Report Lev Facher

‘It’s soul-draining’: Health workers deployed to Covid hot zones are overwhelmed by deaths among the unvaccinated

Exclusive Adam Feuerstein, Matthew Herper and Damian Garde

Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug

Special Report Nicholas St. Fleur and Hyacinth Empinado

Watch: An unusual 30th birthday gift: Why I got a colonoscopy so young — and documented every step

Special Report Nicholas St. Fleur

Chadwick Boseman’s tragedy is America’s tragedy: In colorectal cancer hot spots, young men are dying at higher rates

Prescription Politics Lev Facher

Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds

Special Report Olivia Goldhill

Shuttered hospitals, soaring Covid-19 deaths: Rural Black communities lose a lifeline in the century’s worst health crisis

Special Report Andrew Joseph

Special Report

Most Read

From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy

How Paxlovid came to be: From the germ of an idea to a vital tool against Covid

Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel

20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?

How medicine erased Black women from a ‘white man’s disease’

Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink

More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows

As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance

All Coverage

To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA

Facebook is receiving sensitive medical information from hospital websites

‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a waitlist

Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up

Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines

NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads

Why formally ending the pandemic is going to be a huge headache for the entire health care system

The nation hasn’t made much progress on health equity. These leaders forged ahead anyway

How a decades-old database became a hugely profitable dossier on the health of 270 million Americans

Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain

It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall

‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world

A hospital, and a family, lost during the pandemic

A community pioneer lost, and remembered

The land as medicine

The Guardian of the Glades

DISTANCED: Pandemic stories of Black life in the rural South

‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby

‘It’s soul-draining’: Health workers deployed to Covid hot zones are overwhelmed by deaths among the unvaccinated

Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug

Watch: An unusual 30th birthday gift: Why I got a colonoscopy so young — and documented every step

Chadwick Boseman’s tragedy is America’s tragedy: In colorectal cancer hot spots, young men are dying at higher rates

Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds

Shuttered hospitals, soaring Covid-19 deaths: Rural Black communities lose a lifeline in the century’s worst health crisis

‘It’s not a cure’: A gene therapy is opening a new chapter for children, but challenges endure

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day